Michael Fischer, MD, MS (he/him)
FOUNDER & DIRECTOR
Dr. Fischer is a general internist, epidemiologist, and health services researcher. He is Chief of the Section of General Internal Medicine at Boston Medical Center (BMC) and a Professor of Medicine at Boston University Chobanian & Avedisian School of Medicine. He practices primary care internal medicine at BMC’s safety-net clinic and supervises residents in both the outpatient and inpatient settings. With extensive experience in designing and evaluating interventions to improve medication use, he has conducted numerous studies demonstrating the potential gains from improved prescribing. In 2010 he and Dr. Jerry Avorn co-founded NaRCAD and since then he has led its growth and has published on the principles of academic detailing and its application to a range of clinical areas.
Dr. Fischer's research interests in addition to AD include Medicaid policy, prescription drug reimbursement, electronic prescribing, and medication adherence. Dr. Fischer earned his medical degree from the Yale School of Medicine and a Master of Science degree in health policy and management from the Harvard T.H. Chan School of Public Health. He completed residency training in primary care internal medicine at Brigham & Women’s Hospital. He spent over 20 years at Brigham and Women’s Hospital as a clinician-researcher in the Division of Pharmacoepidemiology and Pharmacoeconomics and was a faculty member at Harvard Medical School and the Harvard School of Public Health where he taught courses on research methods. He has served on advisory or grant review panels for AHRQ, the Department of Health and Human Services, and the FDA and is currently the Chair of PCORI’s Advisory Panel on Clinical Effectiveness and Decision Science.
Back to Our Team
Dr. Fischer's research interests in addition to AD include Medicaid policy, prescription drug reimbursement, electronic prescribing, and medication adherence. Dr. Fischer earned his medical degree from the Yale School of Medicine and a Master of Science degree in health policy and management from the Harvard T.H. Chan School of Public Health. He completed residency training in primary care internal medicine at Brigham & Women’s Hospital. He spent over 20 years at Brigham and Women’s Hospital as a clinician-researcher in the Division of Pharmacoepidemiology and Pharmacoeconomics and was a faculty member at Harvard Medical School and the Harvard School of Public Health where he taught courses on research methods. He has served on advisory or grant review panels for AHRQ, the Department of Health and Human Services, and the FDA and is currently the Chair of PCORI’s Advisory Panel on Clinical Effectiveness and Decision Science.
Back to Our Team